Source link : https://www.newshealth.biz/health-news/sglt-2-inhibitors-top-other-diabetes-medications-for-eye-safety/
STOCKHOLM — The sodium glucose co-transporter 2 (SGLT2) class of diabetes medications may offer more protection against diabetic retinopathy as compared with other hypoglycemic agents, an analysis of a large commercial database suggested. SGLT2 inhibitors, such as empagliflozin (Jardiance) and dapagliflozin (Farxiga), reduced the risk of sight-threatening retinopathy by 21-39% versus GLP-1 receptor agonists, DPP-4 […]
Author : News Health
Publish date : 2024-07-20 17:17:41
Copyright for syndicated content belongs to the linked Source.
Categories